%PDF-1.4
%
137 0 obj
<>
endobj
134 0 obj
<>
endobj
307 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-12-09T12:39:17Z
2024-03-29T05:55:46-07:00
QuarkXPressª: AdobePS 8.8.0 (301)
2024-03-29T05:55:46-07:00
application/pdf
Heather
2003-851.jan
uuid:178f8549-1dd2-11b2-0a00-f10827bd3700
uuid:178f854b-1dd2-11b2-0a00-5b0000000000
endstream
endobj
121 0 obj
<>
endobj
123 0 obj
<>
endobj
122 0 obj
<>
endobj
124 0 obj
<>
endobj
84 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 113 0 R/Type/Page>>
endobj
87 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 115 0 R/Type/Page>>
endobj
314 0 obj
[319 0 R]
endobj
315 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
13.5 787.5 585 -783 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 74.4 736.1941 Tm
(Intern Med 1993; 153:1337-42.)Tj
-2.175 -1.25 Td
[(29.)-875 (Stratford PW)92 (, Binkley JM, Riddle DL, Guyatt GH. Sensitivity to)]TJ
2.175 -1.25 Td
(change of the Roland-Morris Back Pain Questionnaire: part 1. Phys)Tj
0 -1.25 TD
[(Ther 1998; 78:1)37 (186-96.)]TJ
-2.175 -1.25 Td
[(30.)-875 (T)70 (erwee CB, Dekker FW)92 (, Mourits MP)111 (, et al. Interpretation and)]TJ
2.175 -1.25 Td
[(validity of changes in scores on the Graves\325)-201 (ophthalmopathy quality)]TJ
T*
[(of life questionnaire \(GO-QOL\) after dif)18 (ferent treatments. Clin)]TJ
T*
(Endocrinol \(Oxf\) 2001; 54:391-8.)Tj
-2.175 -1.25 Td
[(31.)-875 (W)80 (ells GA, )18 (T)35 (ugwell P)111 (, Kraag GR, Baker PR, Groh J, Redelmeier)]TJ
2.175 -1.25 Td
[(DA. Minimum important dif)18 (ference between patients with )]TJ
T*
[(rheumatoid arthritis: the patient\325)55 (s perspective. J Rheumatol 1993;)]TJ
0 Tc 0 Tw T*
(20:557-60.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(32.)-875 (Redelmeier DA, Goldstein RS, Min ST)74 (, Hyland RH. Spirometry)]TJ
2.175 -1.25 Td
[(and dyspnea in patients with COPD. )18 (When small dif)18 (ferences mean)]TJ
T*
[(little. Chest 1996; 109:1)37 (163-8.)]TJ
-2.175 -1.25 Td
[(33.)-875 (Redelmeier DA, Bloch DA, Hickam DH. )55 (Assessing predictive)]TJ
2.175 -1.25 Td
(accuracy: how to compare Brier scores. J Clin Epidemiol 1991;)Tj
0 Tc 0 Tw T*
[(44:1)37 (141-6.)]TJ
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(34.)-875 (Hemingway H, Staf)18 (ford M, Stansfeld S, Shipley M, Marmot M. Is)]TJ
2.175 -1.25 Td
(the SF-36 a valid measure of change in population health? Results)Tj
T*
[(from the )18 (Whitehall II Study)65 (. BMJ)-275 (1997; 315:1273-9.)]TJ
-2.175 -1.25 Td
[(35.)-875 (Ross M. Relationship of implicit theories to the construction of )]TJ
2.175 -1.25 Td
(personal histories. Psychol Rev 1989; 96:341-57.)Tj
-2.175 -1.25 Td
[(36.)-875 (W)60 (yrwich KW)92 (, Nienaber NA, )18 (T)35 (ierney )18 (WM, )18 (W)80 (olinsky FD. Linking)]TJ
2.175 -1.25 Td
(clinical relevance and statistical significance in evaluating )Tj
T*
(intra-individual changes in health-related quality of life. Med Care)Tj
0 Tc T*
(1999; 37:469-78.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(37.)-875 (Riddle DL, Stratford PW)92 (, Binkley JM. Sensitivity to change of the)]TJ
2.175 -1.25 Td
[(Roland-Morris Back Pain Questionnaire: part 2. Phys )18 (Ther 1998;)]TJ
0 Tc 0 Tw T*
[(78:1)37 (197-207.)]TJ
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(38.)-875 (Zar JH. Biostatistical analysis. Upper Saddle River)40 (, N.J.: )]TJ
2.175 -1.25 Td
[(Prentice-Hall, 1996:1 v)65 (. \(various pagings\).)]TJ
-2.175 -1.25 Td
[(39.)-875 (W)60 (yrwich KW)92 (, )18 (T)35 (ierney )18 (WM, )18 (W)80 (olinsky FD. Further evidence )]TJ
2.175 -1.25 Td
(supporting an SEM-based criterion for identifying meaningful)Tj
T*
(intra-individual changes in health-related quality of life. J Clin)Tj
T*
(Epidemiol 1999; 52:861-73.)Tj
30.825 43.75 Td
[(40.)-875 (Ruperto N, Ravelli )55 (A, Pistorio )55 (A, et al. )18 (The Italian version of the)]TJ
2.175 -1.25 Td
[(Childhood Health )55 (Assessment Questionnaire \(CHAQ\) and the)]TJ
T*
(Child Health Questionnaire \(CHQ\). Clin Exp Rheumatol 2001;)Tj
0 Tw T*
(19:S91-5.)Tj
0.02499 Tw -2.175 -1.25 Td
[(41.)-875 (Lovell DJ, Giannini EH, Reif)18 (f )55 (A, et al. Etanercept in children with)]TJ
2.175 -1.25 Td
(polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology)Tj
T*
(Collaborative Study Group. N Engl J Med 2000; 342:763-9.)Tj
-2.175 -1.25 Td
[(42.)-875 (Oen K, Malleson PN, Cabral DA, Rosenber)18 (g )55 (AM, Petty RE,)]TJ
2.175 -1.25 Td
(Cheang M. Disease course and outcome of juvenile rheumatoid)Tj
T*
(arthritis in a multicenter cohort. J Rheumatol 2002; 29:1989-99.)Tj
-2.175 -1.25 Td
[(43.)-875 (Brunner HI, Kim KN, Ballinger SH, et al. Medication choices in)]TJ
2.175 -1.25 Td
(juvenile rheumatoid arthritis. J Clin Rheumatol 2001;7:295-300.)Tj
-2.175 -1.25 Td
[(44.)-875 (Llewellyn-Thomas HA, Schwartz CE. Response shift ef)18 (fects in)]TJ
2.175 -1.25 Td
[(patients\325)-201 (evaluations of health states: )18 (The influences of )]TJ
T*
[(expectations, comparisons, actual health status, and mood. )55 (Amer)]TJ
0 Tc T*
[(Psychol )55 (Assoc Press. )18 (W)80 (ashington, D.C., 2000:109-122.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(45.)-875 (Llewellyn-Thomas HA, Sutherland HJ, )18 (Thiel EC. Do patients\325)]TJ
2.175 -1.25 Td
(evaluations of a future health state change when they actually enter)Tj
T*
(that state? Med Care 1993; 31:1002-12.)Tj
-2.175 -1.25 Td
[(46.)-875 (Redelmeier DA, Kahneman D. Patients\325)-201 (memories of painful )]TJ
2.175 -1.25 Td
(medical treatments: real-time and retrospective evaluations of two)Tj
T*
(minimally invasive procedures. Pain 1996; 66:3-8.)Tj
-2.175 -1.25 Td
[(47.)-875 (Feldman B, Lam C, J M, )37 (Y)100 (oung NL. )55 (Ability vs. Disability: a )]TJ
2.175 -1.25 Td
[(re-scaled Childhood Health )55 (Assessment Questionnaire \(CHAQ\) )]TJ
T*
[(performs better and is more sensitive [abstract]. )55 (Arthritis Rheum)]TJ
0 Tc T*
(2001;44 Suppl: S381.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(48.)-875 (Whitney-Mahoney KJ, )37 (Y)100 (oung NL, Feldman BM, Badely EM.)]TJ
2.175 -1.25 Td
(Alternative scoring methods improve the responsiveness of the)Tj
T*
[(Childhood Health )55 (Assessment Questionnaire [abstract]. )55 (Arthritis)]TJ
0 Tc T*
(Rheum 2001;44 Suppl:S381.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(49.)-875 (Rasch G. )55 (An item analysis which takes individual dif)18 (ferences into)]TJ
2.175 -1.25 Td
(account. Br J Math Stat Psychol 1966; 19:49-57.)Tj
ET
0 0 0 1 K
53.468 76.5 m
558.468 76.5 l
S
0 0 0 0 k
494.29 69.365 64.178 -15.665 re
f*
BT
0 0 0 1 k
/T1_1 1 Tf
0 Tc 0 Tw 8 0 0 8 545.468 56.4344 Tm
(161)Tj
ET
0 0 0 0 k
53.532 70.511 203 -16.755 re
f*
BT
0 0 0 1 k
/T1_1 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 54.532 56.4901 Tm
[(Brunner)111 (, et al: Childhood HAQ)]TJ
ET
0 0 0 0 k
/GS0 gs
102.194 81.583 407.5 -10.833 re
f*
0.5 w
/GS1 gs
102.194 81.583 407.5 -10.833 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 g
ET
/GS2 gs
BT
/T1_2 8 Tf
106.328 74 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2005. All rights reserved.)Tj
ET
Q
BT
0 g
/GS3 gs
/T1_3 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS3 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS3 gs
-16.72996 0 Td
(Downloaded on March 29, 2024 from )Tj
ET
endstream
endobj
115 0 obj
<>stream
8;Z\7>Ah>4%+G/.W9^Ne/q`tmY&RsY
c#ATaL6/ht^02-/3P0kPKHum2BpX37Q4uEc&F_MT9BS9l@g%Ti.Yc8b-mtg6'Ci9$
38d,^#e;>pTgXgl,+)UomNGZ*>WJ4h%T/NCCP_?%nf1)Ii.U*n2Uhl=j_Kno+'hpe>
endstream
endobj
119 0 obj
[/Indexed/DeviceRGB 255 118 0 R]
endobj
118 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
149 0 obj
<>
endobj
140 0 obj
<>
endobj
181 0 obj
<>
endobj
313 0 obj
<>
endobj
141 0 obj
<>
endobj
175 0 obj
<>stream
HUiPSY~cd{IMH+:""[7"K"$, "d_bEU
FqQGTi{Zơk&kO9|uSuc&|} {dQBAgcpf L0KM_GrLrSƅcğ4?-A\X\1ٕ-g/otsw%%x&ƭ^{[>Vzg(OKeD)')F$$Q2~M
RZ%臎ieX~b$}ED2OMG%nIhN-
$p|7mq,cccaX1#0&rLRMvBk1j ߲7`eW--\
g3zb!ׂ[jI5
V۬͠*z`dzZ~CäA+aN\+ex.:pz>WG2*yシ"n_6WjX&AJYRч>BU9h2GIY9oxY}
6\2r0n1 o"1L%!'JFy<RtH"r~M5xPCذBI?{,H2xQ7=3|ep4"d~)ȶ!]04!z7+#kqsdT.+*7+6w "G瓙fZZ0( jpf 6EGwhO:Q-~̜~?\)+@Z x\14pr=+DFV$D&R͉BmyW[;uゖgAP#^W5cz(aTCsKO~Slq**rbe̖kJT@dߒ1ax@xIw+
/4lz<{2T<|Ev:>g_AjJx?lkab`۩-B9B9KK>b]_5~tc'QЂ?RXp^\031m6Q:o]J&NrUI畝(UhY_S+{Hcq kS{AA%lkgĸ;ſi2^mq$s2ElNF|aT*:5+ap9w,X\U#r3-QMxPZ ~ o[5Zπ۴;aS"wV}9O>
Uڣ[=¶+4ݽ^6nR{%mY3Tuo<~m.rvJ?յOwOF"=S.e۴CTcB<3}m}q#QFk7BcG_@}JN}_ηnٛ XEcikO~LB"GȾ-/Uy=Avu=r
cC=3Vp.f' jeB\rA;/'^R,V+mp|6.ws7y.s{ʔ bS_+q$qÑEԪn9ݚ3*G٧*j2gJ,aSxtg\&2pr -䞵RD+^
*5H
3z-Ȗ\PU EujݮZ݉e("konD"ejuBazQjyVM^EiBwyƾgcmLhB+7ZY9xjB`mbV1_«=;7{e5떂ڲjZ+/A *BIPBx&H#!ŀ
Z"(/ݵXz.8{[w|ι'ZnK'1
}J!
Cd`dR Ȟa"B1"ib"Fx-/y#.biM:(Fk }n"$KyA,M[ѴL<8݊}<:`tWyGNͬ1:bw&S"8ϵrub#G4# 9y [/*Yf,kA[W,w[⥇ۥndqǽaZr/o̊f?Yt|6x9`3,ŵ7wm<_
nOr1_%@Ω{SmDZA!bZ ;˃CD?$<|,3Vu>Z